Alliance Pharma plc (LON:APH – Get Free Report) reached a new 52-week high during trading on Wednesday . The company traded as high as GBX 47.95 ($0.63) and last traded at GBX 45.65 ($0.60), with a volume of 1492234 shares trading hands. The stock had previously closed at GBX 46.10 ($0.60).
Alliance Pharma Stock Down 0.2 %
The company has a quick ratio of 1.42, a current ratio of 2.93 and a debt-to-equity ratio of 47.46. The business’s fifty day moving average price is GBX 40.51 and its 200 day moving average price is GBX 37.86. The firm has a market capitalization of £246.50 million, a PE ratio of -760.00, a PEG ratio of 1.04 and a beta of 0.67.
Alliance Pharma Company Profile
Alliance Pharma plc operates as a pharmaceutical company in Europe, the Middle East, Africa, the Asia Pacific, China, and the Americas. The company acquires, markets, and distributes consumer healthcare and prescription medicine products. The company also offers medicines, medical devices, food supplements, and cosmetics.
Read More
- Five stocks we like better than Alliance Pharma
- The 3 Best Blue-Chip Stocks to Buy Now
- Survey Reveals: America’s Most Coveted Businesses in 2024
- Trading Halts Explained
- Top 3 Stocks to Play Oil’s Potential Comeback Rally
- The Most Important Warren Buffett Stock for Investors: His Own
- Analysts See Growth in CrowdStrike Stock Despite July Setback
Receive News & Ratings for Alliance Pharma Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Alliance Pharma and related companies with MarketBeat.com's FREE daily email newsletter.
